The Pcyt2 heterozygous Pcyt2+/− mouse is an attractive model to study the contribution of membrane phospholipid metabolism to NASH as it exhibits similar features to humans, importantly, the association of gradual disease onset and decreased PE synthesis with age17–19, since early disease pathologies are not well established. The gene discussed is PCYT2; the disease is metabolic dysfunction-associated steatohepatitis.